The Use of Subclinical Atherosclerosis Imaging to Guide Preventive Cardiology Management

Curr Cardiol Rep. 2021 May 7;23(6):61. doi: 10.1007/s11886-021-01490-7.

Abstract

Purpose of the review: Clinical atherosclerotic cardiovascular disease (ASCVD) requires years to manifest, providing a window of opportunity for preventive cardiovascular management. Subclinical atherosclerosis imaging leverages this long latency period to estimate and improve future ASCVD risk.

Recent findings: Coronary artery calcium (CAC) scoring has the most robust data in the detection of subclinical atherosclerosis. CAC scan significantly enhances cardiovascular risk stratification in addition to traditional risk models. Coronary computed tomography angiography data show similar strengths in subclinical atherosclerosis detection in addition to plaque morphology characterization with inherent limitations. Carotid intima-media thickness and ankle-brachial index are other modalities whose predictive value becomes incremental when added to the aforementioned modalities. When added to traditional risk models, subclinical atherosclerosis imaging modalities personalize future ASCVD risk stratification and assist in the initiation and rate of intensification of preventive therapies. Emerging imaging techniques exist but further research is required for primetime clinical use.

Keywords: Ankle-brachial index; Carotid intima-media thickness; Coronary Computed Tomography Angiography; Coronary artery calcium scan; Preventive cardiology; Subclinical atherosclerosis.

Publication types

  • Review

MeSH terms

  • Atherosclerosis* / diagnostic imaging
  • Atherosclerosis* / prevention & control
  • Cardiology*
  • Carotid Intima-Media Thickness
  • Coronary Artery Disease* / diagnostic imaging
  • Coronary Artery Disease* / prevention & control
  • Humans
  • Risk Assessment
  • Risk Factors